Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

(2015) M. E. Caplin et al.   ANNALS OF ONCOLOGY

Interobserver Variability for the WHO Classification of Pulmonary Carcinoids

(2014) Dorian R.A. Swarts et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice

(2014) Giuseppe Pelosi et al.   Journal of Thoracic Oncology

Grading the neuroendocrine tumors of the lung: an evidence-based proposal

(2013) G Rindi et al.   ENDOCRINE-RELATED CANCER

Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids

(2013) Arne Warth et al.   VIRCHOWS ARCHIV

TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study

(2012) G. Rindi et al.   JNCI-Journal of the National Cancer Institute

Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors

(2012) Ann E Walts et al.   MODERN PATHOLOGY

Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach

(2012) Tina Zahel et al.   VIRCHOWS ARCHIV

Advances in neuroendocrine lung tumors

(2010) W. D. Travis   ANNALS OF ONCOLOGY

ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on Survival

(2010) Birgit Guldhammer Skov et al.   Journal of Thoracic Oncology

Lung tumours with neuroendocrine differentiation

(2009) William D. Travis   EUROPEAN JOURNAL OF CANCER

Bronchopulmonary Carcinoid: Phenotype and Long-term Outcome in a Single-Institution Series of Italian Patients

(2008) M. Rugge et al.   CLINICAL CANCER RESEARCH